We are live on
!
Find out more
RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$2.05B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+19.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.05B
AUM Growth
+$259M
(+14%)
Cap. Flow
+$4.36M
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
255
New
12
Increased
112
Reduced
101
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oshkosh
OSK
|
+$14.9M |
| 2 |
Upwork
UPWK
|
+$13.9M |
| 3 |
TETRA Technologies
TTI
|
+$10.1M |
| 4 |
Prestige Consumer Healthcare
PBH
|
+$8.64M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$7.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aehr Test Systems
AEHR
|
+$16.9M |
| 2 |
Fabrinet
FN
|
+$11.8M |
| 3 |
CEVA Inc
CEVA
|
+$11.4M |
| 4 |
FOLD
Amicus Therapeutics
FOLD
|
+$11.1M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$7.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.48% |
| 2 | Technology | 28.09% |
| 3 | Industrials | 16.08% |
| 4 | Consumer Discretionary | 7.96% |
| 5 | Communication Services | 5.41% |
No holdings matched the selected filter criteria.
Similar funds
WFMPM
RC
GIM
HBT
IL
BC
SW
SAM
Rice Hall James & Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Rice Hall James & Associates held 255 positions worth $2.05B, up 14% from $1.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rice Hall James & Associates's Q2 2026 filing shows 12 new, 112 increased, 101 reduced and 15 closed positions. Its largest new stake was Oshkosh: 106,011 shares worth $16.3M. The largest sale was Aehr Test Systems, an estimated $16.9M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.
- Rice Hall James & Associates's largest Q2 2026 buy was Oshkosh: 106,011 shares worth $16.3M.
- Rice Hall James & Associates added most to Upwork in Q2 2026, an estimated $13.9M increase.
- Rice Hall James & Associates's biggest Q2 2026 reduction was Aehr Test Systems, cutting an estimated $16.9M.
- Rice Hall James & Associates fully exited Amicus Therapeutics in Q2 2026, selling an estimated $11.1M.
- Rice Hall James & Associates's ten largest holdings make up 24% of its $2.05B portfolio in Q2 2026.
- Rice Hall James & Associates opened 12 new positions and closed 15 in Q2 2026.
- Rice Hall James & Associates's portfolio value rose 14% quarter-over-quarter to $2.05B.
Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.